GSA CAPITAL PARTNERS LLP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 40 filers reported holding AC IMMUNE SA in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q4 2021$362,000
+212.1%
73,046
+334.8%
0.04%
+55.2%
Q1 2020$116,000
-57.5%
16,800
-47.7%
0.03%
-9.4%
Q4 2019$273,000
+92.3%
32,100
+12.2%
0.03%
+68.4%
Q3 2019$142,000
+29.1%
28,600
+107.2%
0.02%
+216.7%
Q3 2018$110,000
-79.0%
13,801
-72.8%
0.01%
-78.6%
Q1 2017$525,000
+14.9%
50,697
+43.9%
0.03%
+3.7%
Q4 2016$457,00035,2330.03%
Other shareholders
AC IMMUNE SA shareholders Q1 2022
NameSharesValueWeighting ↓
Duquesne Family Office 1,500,000$24,705,0002.18%
Monashee Investment Management LLC 275,000$4,529,0001.59%
SPHERA FUNDS MANAGEMENT LTD. 79,800$1,314,0000.21%
Hillhouse Capital Management 550,000$9,059,0000.18%
Temasek Holdings (Private) Ltd 1,337,500$22,029,0000.18%
PointState Capital LP 425,000$7,000,0000.07%
Artal Group S.A. 150,000$2,471,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 87,900$1,448,0000.04%
Schonfeld Strategic Advisors LLC 14,779$243,0000.04%
Point72 Hong Kong Ltd 4,000$66,0000.04%
View complete list of AC IMMUNE SA shareholders